A phase II prospective trial correlating progression-free survival (PFS) with CYP2D6 activity in patients with metastatic breast cancer treated with tamoxifen: ECOG-ACRIN E3108.
暂无分享，去创建一个
Minetta C. Liu | G. Sledge | D. Moore | M. Goetz | J. Sparano | T. Skaar | C. Lohrisch | V. Stearns | D. Flockhart | B. Schneider | A. O'neill | D. Villa | P. Silverman | P. Cheema | C. V. Sologuren